Neha Mehta-Shah, MD, MSCI

Neha Mehta-Shah, MD, MSCI, is an assistant professor in the Division of Oncology at Washington University School of Medicine and specializes in lymphoma. She earned her medical degree from Northwestern University’s Feinberg School of Medicine, and master’s of science in clinical investigation from Washington University School of Medicine. Mehta-Shah completed residency training in internal medicine at New York Presbyterian-Weill Cornell Medical Center, where she was selected as chief resident. She then completed fellowship in hematology/oncology at Memorial Sloan Kettering Cancer Center. She is board certified in medical oncology, hematology and internal medicine.

Mehta-Shah’s primary focus is the development of novel therapies for rare lymphomas, including T-cell lymphomas and biomarkers, to help predict response or resistance to therapy. She is the principal investigator on several clinical trials in lymphoma, and extramural and intramural grants. She serves on the National Comprehensive Cancer Network guidelines for T-cell lymphoma. She also has an interest in medical education and is a core faculty member of the Hematology/Oncology Fellowship program.

Mehta-Shah spends most of her time outside of work with her two children, ages four and one.